New PET tracer aims to spot Hard-to-Find HER2 cancers
NCT ID NCT06828588
First seen Oct 31, 2025 · Last updated Jun 10, 2026 · Updated 23 times
Summary
This early-phase study tests whether a special radioactive tracer called [68Ga]Ga-ABY-025 can make HER2-positive tumors show up better on PET scans. About 30 adults with advanced or metastatic HER2-positive cancers (like breast, stomach, or head and neck cancer) who are already on standard HER2-targeted therapy will receive the tracer and be scanned. The main goal is to check the tracer's safety and see if it helps doctors find more tumors than current methods.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Vanderbilt University Medical Center
RECRUITINGNashville, Tennessee, 37232, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.